PPD

PPD is a global contract research organization (CRO) that provides comprehensive drug development, laboratory, and lifecycle management services to the pharmaceutical and biotechnology industries. The company delivers integrated solutions across the entire drug development continuum, from early discovery and preclinical research through clinical trials and post-approval studies. Its technical approach emphasizes operational excellence and scientific rigor to accelerate the delivery of new therapies.

The company was founded in 1985 by Fred Eshelman, Pharm. D., initially operating as a one-person consulting firm. Eshelman's insight into the growing need for outsourced expertise in pharmaceutical development led him to expand PPD’s scope beyond consulting to include broader development services the following year. This strategic shift positioned the company to become a leading partner in the complex process of bringing new medicines to market.

PPD serves a diverse client base, including pharmaceutical, biotechnology, medical device, and government organizations seeking to advance their therapeutic pipelines. The company's vision centers on improving global health by helping its customers efficiently navigate the complexities of drug development. PPD aims to continue supporting the rapid and reliable delivery of life-changing treatments to patients worldwide.